dinitrofluorobenzene has been researched along with Dermatitis Medicamentosa in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergot, AS; Frazer, IH; Mattarollo, SR; Mittal, D; Tran, LS | 1 |
Chiba, K; Goto, M; Gusovsky, F; Inoue, Y; Ishii, N; Kuboi, Y; Muramoto, K; Omae, T; Shirota, H; Wang, YJ | 1 |
Chang, T; Hao, W; Li, Y; Sun, J | 1 |
Iwamura, H; Kaya, T; Matsui, T; Miyagawa, N; Ueda, Y | 1 |
Dobozy, A; Farkas, A; Kemény, L | 1 |
5 other study(ies) available for dinitrofluorobenzene and Dermatitis Medicamentosa
Article | Year |
---|---|
Human papillomavirus e7 oncoprotein transgenic skin develops an enhanced inflammatory response to 2,4-dinitrochlorobenzene by an arginase-1-dependent mechanism.
Topics: Animals; Arginase; Dinitrofluorobenzene; Drug Eruptions; Ear, External; Female; Human papillomavirus 16; Immunity, Innate; Male; Mice, Inbred C57BL; Mice, Knockout; Myeloid Cells; Papillomavirus E7 Proteins; Papillomavirus Infections; Skin; Th2 Cells | 2014 |
E6201, a novel kinase inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-1 and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-1: in vivo effects on cutaneous inflammatory respon
Topics: Administration, Topical; Animals; Antineoplastic Agents, Phytogenic; Croton Oil; Dinitrofluorobenzene; Diterpenes; Drug Eruptions; Hyperplasia; Indicators and Reagents; Interleukin-17; Interleukin-23; Lactones; Male; MAP Kinase Kinase Kinase 1; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Ornithine Decarboxylase; Peroxidase; Protein Kinase Inhibitors; Psoriasis; Skin; T-Lymphocytes; Tetradecanoylphorbol Acetate | 2010 |
Preliminary pharmacological study of purified snake enzymatic cream isolated from Agkistrodon Halys venom.
Topics: Agkistrodon; Animals; Dinitrofluorobenzene; Dose-Response Relationship, Drug; Drug Eruptions; Erythema; Female; Guinea Pigs; Male; Skin; Skin Irritancy Tests; Viper Venoms | 2003 |
Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Area Under Curve; Camphanes; Cannabinoids; Dinitrofluorobenzene; Dioxoles; Disease Models, Animal; Drug Eruptions; Ear, External; Female; Indomethacin; Inflammation; Lymph Nodes; Mice; Mice, Inbred BALB C; Pyrazoles; Quinolones; Receptor, Cannabinoid, CB2; RNA, Messenger; Time Factors | 2005 |
Low-dose dithranol treatment and tape stripping induce tolerance to dithranol in a mouse ear oedema model.
Topics: Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Croton Oil; Dinitrofluorobenzene; Drug Administration Schedule; Drug Eruptions; Drug Tolerance; Ear Diseases; Ear, External; Edema; Male; Mice; Mice, Inbred Strains; Superoxide Dismutase | 2002 |